4//SEC Filing
Coiante Scott M 4
Accession 0001140361-19-018071
CIK 0001781983other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:15 PM ET
Size
6.4 KB
Accession
0001140361-19-018071
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to Buy)
2019-10-07+150,824→ 150,824 totalExercise: $15.00Exp: 2029-10-02→ Common Stock (150,824 underlying) - Purchase
Common Stock
2019-10-07$15.00/sh+2,500$37,500→ 2,500 total
Footnotes (1)
- [F1]Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001608536
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 7:15 PM ET
- Size
- 6.4 KB